These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 24838674)

  • 1. Oncoapoptotic markers in oral cancer: prognostics and therapeutic perspective.
    Jain A; Bundela S; Tiwari RP; Bisen PS
    Mol Diagn Ther; 2014 Oct; 18(5):483-94. PubMed ID: 24838674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncoapoptotic signaling and deregulated target genes in cancers: special reference to oral cancer.
    Khan Z; Bisen PS
    Biochim Biophys Acta; 2013 Aug; 1836(1):123-45. PubMed ID: 23602834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Progress in targeted therapeutic drugs for oral squamous cell carcinoma.
    Liu L; Chen J; Cai X; Yao Z; Huang J
    Surg Oncol; 2019 Dec; 31():90-97. PubMed ID: 31550560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of Jumonji-C domain-containing protein 5 inhibits proliferation by silibinin in the oral cancer PDTX model.
    Yang CY; Tsao CH; Hsieh CC; Lin CK; Lin CS; Li YH; Chang WC; Cheng JC; Lin GJ; Sytwu HK; Wang YL; Chen YW
    PLoS One; 2020; 15(7):e0236101. PubMed ID: 32678829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma.
    Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C
    J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell division cycle associated 1 as a novel prognostic biomarker and therapeutic target for oral cancer.
    Thang PM; Takano A; Yoshitake Y; Shinohara M; Murakami Y; Daigo Y
    Int J Oncol; 2016 Oct; 49(4):1385-93. PubMed ID: 27499128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. OMICS, Oral Cancer Molecular Landscapes, and Clinical Practice.
    D'Souza W; Saranath D
    OMICS; 2017 Dec; 21(12):689-703. PubMed ID: 29173078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma.
    Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY
    J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer.
    Mahdian-Shakib A; Dorostkar R; Tat M; Hashemzadeh MS; Saidi N
    Biomed Pharmacother; 2016 Dec; 84():592-600. PubMed ID: 27694003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic mechanisms in oral carcinogenesis.
    Gasche JA; Goel A
    Future Oncol; 2012 Nov; 8(11):1407-25. PubMed ID: 23148615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Salivary Biomarkers in Oral Cancer Detection.
    Khurshid Z; Zafar MS; Khan RS; Najeeb S; Slowey PD; Rehman IU
    Adv Clin Chem; 2018; 86():23-70. PubMed ID: 30144841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNAs as effective surrogate biomarkers for early diagnosis of oral cancer.
    Cao M; Zheng L; Liu J; Dobleman T; Hu S; Go VLW; Gao G; Xiao GG
    Clin Oral Investig; 2018 Mar; 22(2):571-581. PubMed ID: 29299731
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropilin-1 promotes epithelial-to-mesenchymal transition by stimulating nuclear factor-kappa B and is associated with poor prognosis in human oral squamous cell carcinoma.
    Chu W; Song X; Yang X; Ma L; Zhu J; He M; Wang Z; Wu Y
    PLoS One; 2014; 9(7):e101931. PubMed ID: 24999732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating effect of hesperetin on the molecular expression pattern of apoptotic and cell proliferative markers in 7,12-dimethylbenz(a)anthracene-induced oral carcinogenesis.
    Babukumar S; Vinothkumar V; Ramachandhiran D
    Arch Physiol Biochem; 2020 Dec; 126(5):430-439. PubMed ID: 30663412
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metallic gold and bioactive quinacrine hybrid nanoparticles inhibit oral cancer stem cell and angiogenesis by deregulating inflammatory cytokines in p53 dependent manner.
    Satapathy SR; Nayak A; Siddharth S; Das S; Nayak D; Kundu CN
    Nanomedicine; 2018 Apr; 14(3):883-896. PubMed ID: 29366881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of IGFBP-2 in oral cancer metastasis.
    Tsai YF; Chou HC; Liou MH; Liao EC; Cheng CT; Chang SJ; Chan HL
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166143. PubMed ID: 33864954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VEGF mediated signaling in oral cancer.
    Lin X; Khalid S; Qureshi MZ; Attar R; Yaylim I; Ucak I; Yaqub A; Fayyaz S; Farooqi AA; Ismail M
    Cell Mol Biol (Noisy-le-grand); 2016 Dec; 62(14):64-68. PubMed ID: 28145862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating the role of microRNAs alterations in oral squamous cell carcinoma.
    Aali M; Mesgarzadeh AH; Najjary S; Abdolahi HM; Kojabad AB; Baradaran B
    Gene; 2020 Oct; 757():144936. PubMed ID: 32640301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The scorpion venom peptide BmKn2 induces apoptosis in cancerous but not in normal human oral cells.
    Satitmanwiwat S; Changsangfa C; Khanuengthong A; Promthep K; Roytrakul S; Arpornsuwan T; Saikhun K; Sritanaudomchai H
    Biomed Pharmacother; 2016 Dec; 84():1042-1050. PubMed ID: 27780132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The negative prognostic value of TRAIL overexpression in oral squamous cell carcinomas does not preclude the potential therapeutic use of recombinant TRAIL.
    Carinci F; Monasta L; Rubini C; Stramazzotti D; Palmieri A; Melloni E; Knowles A; Ronfani L; Zauli G; Secchiero P
    Invest New Drugs; 2012 Apr; 30(2):810-8. PubMed ID: 21086019
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.